Although different clinical investigations consistently showed that liver CYP2E1 activity is statistically greater in obesity and NAFLD, this activity is highly variable in obese patients [21,55-58]. The gene discussed is CYP2E1; the disease is obesity due to melanocortin 4 receptor deficiency.